| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 0 | 2.161 | 29.804 | 173.612 | 587.295 | 2.290.065 | 4.089.417 |
| Total Income - EUR | - | - | 0 | 1 | 2.171 | 30.098 | 174.110 | 592.195 | 2.289.150 | 4.090.069 |
| Total Expenses - EUR | - | - | 574 | 30.319 | 59.023 | 73.074 | 130.701 | 393.808 | 2.068.176 | 3.729.066 |
| Gross Profit/Loss - EUR | - | - | -574 | -30.318 | -56.852 | -42.976 | 43.409 | 198.388 | 220.974 | 361.002 |
| Net Profit/Loss - EUR | - | - | -574 | -30.318 | -56.874 | -43.265 | 41.975 | 193.589 | 192.130 | 312.301 |
| Employees | - | - | 0 | 1 | 2 | 1 | 2 | 4 | 5 | 6 |
Check the financial reports for the company - Komtur Pharmaceuticals Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 32 | 9 | 9 | 1.057 | 1.579 | 7.236 | 150.497 |
| Current Assets | - | - | 24.793 | 50.682 | 49.984 | 62.976 | 173.682 | 242.644 | 1.481.893 | 2.685.862 |
| Inventories | - | - | 0 | 647 | 36.181 | 35.318 | 34.534 | 436 | 34.070 | 374.861 |
| Receivables | - | - | 0 | 1.149 | 3.299 | 21.690 | 33.581 | 204.748 | 1.230.061 | 2.163.588 |
| Cash | - | - | 24.793 | 48.886 | 10.504 | 5.968 | 105.566 | 37.460 | 217.762 | 147.413 |
| Shareholders Funds | - | - | 24.382 | -6.384 | -63.134 | -105.202 | -60.894 | 132.506 | 324.234 | 634.723 |
| Social Capital | - | - | 24.956 | 24.498 | 24.023 | 23.568 | 23.045 | 23.117 | 23.047 | 22.918 |
| Debts | - | - | 411 | 57.098 | 113.127 | 168.186 | 235.633 | 111.968 | 1.165.518 | 2.203.773 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7311 - 7311" | |||||||||
| CAEN Financial Year |
7311
|
|||||||||
Comments - Komtur Pharmaceuticals Srl